Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 269-276

  El Bab, Mohamed Fath ^a   Shawky, Nashaat ^b   Al Sisi, Ali ^c   Akhtar, Mohamed ^c  

^a Suez Canal University   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c Ohud Hospital   (Saudi Arabia)

Author keywords

Diabetes complications; Diabetic retinopathy; Risk factors

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NONPROLIFERATIVE DIABETIC RETINOPATHY; PREVALENCE; QUESTIONNAIRE; RETINOPATHY; RISK ASSESSMENT; RISK FACTOR; SAUDI ARABIA; SEX RATIO;

EID: 84857715797     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S27363     Document Type: Article

References (53)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025, prevalence, numerical estimates and projection. Diabetes Care. 1998;21:1414-1431.
2. King H, Rewers M. WHO ad hoc diabetes reporting group, global estimates for prevalence of diabetes and IGT in adults. Diabetes Care. 1993;16:157-177.
3. Danaei G, Finucane MM, Lu Y, et al; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31-40.
4. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J. 2004;25:1603-1610.
5. Alqurashi KA, Aljabri KS, Bokhari SA. Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med. 2011;31:19-23.
6. Nakazawa T. Mechanism of N-methyl-D-aspartate-induced retinal ganglion cell death. Nippon Ganka Gakkai Zasshi. 2009;113:1060-1067. Japanese.
7. American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2000;23 Suppl 1:S73-S76.
8. Al-Shammari KH, Al-Meraghi O, Nasif A, Al-Otaibi S. The prevalence of diabetic retinopathy and associated risk factors in type 2 diabetes mellitus in Al-Naeem area (Kuwait). Middle East Journal of Family Medicine. 2005;3:1-8.
9. Centers for Disease Control and Prevention. Blindness caused by diabetes-Massachusetts, 1987-1994. MMWR Morb Mortal Wkly Rep. 1996;45:937-941.
10. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
11. Bamashmus MA, Gunaid AA, Khandekar RB. Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study. Indian J Ophthalmol. 2009;57: 293-298.
12. Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009;55:92-96.
13. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
14. Verdaguer J, Zanolli M, Sepúlveda G, García de Los Ríos M, Domínguez A. Natural history of diabetic retinopathy in a retrospective cohort of type 1 diabetics. Rev Med Chil. 2009;137:1145-1152. Spanish.
15. 1C and fasting glucose criteria to diagnose diabetes among US adults. Diabetes Care. 2010;33:95-97.
16. Wang S, Xu L, Jonas JB, et al. Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population. The Beijing Eye Study. Ophthalmology. 2009;116:2373-2380.
17. Morales A. A better future for children with type 1 diabetes: Review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. J Ark Med Soc. 2009;106:90-93.
18. Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabet Med. 2008;25:536-542.
19. Gerchman F, Zanatta CM, Burttet LM, et al. Type 2 diabetes mellitus in Southern Brazil. Braz J Med Biol Res. 2008;41:668-673.
20. Bhatnagar A, Ghauri AJ, Hope-Ross M, Lip PL. Diabetic retinopathy in pregnancy. Curr Diabetes Rev. 2009;5:151-156.
21. Neckell A, Munteanu M. Diabetes mellitus and pregnancy. Oftalmologia. 2009;53:118-122. Romanian.
22. Placha G, Canani LH, Warram JH, Krolewski AS. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis. 2005;12:155-169.
23. Casas JP, Cooper J, Miller GJ, Hingorani AD, Humphries SE. Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies. Ann Hum Genet. 2006;70:145-169.
24. Esteves J, da Rosa CM, Kramer CK, Osowski LE, Milano S, Canani LH. Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation. Diabetol Metab Syndr. 2009;1:13.
25. Tapp RJ, Shaw JE, Harper CA, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26:1731-1737.
26. Voutilainen-Kaunisto RM, Teräsvirta ME, Uusitupa MI, Niskanen LK. Occurrence and predictors of retinopathy and visual acuity in type 2 diabetic patients and control subjects. 10-year follow-up from the diagnosis. J Diabetes Complications. 2001;15:24-33.
27. Fong DS, Aiello L, Gardner TW, et al. American Diabetes Association. Retinopathy in diabetes. Diabetes Care. 2004;27 Suppl 1:S84-S87.
28. Saadi H, Carruthers SG, Nagelkerke N, et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract. 2007;78:369-377.
29. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination survey. JAMA. 2002;287:356-359.
30. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27 Suppl 1:S5-S10.
31. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2008;31 Suppl 1:S12-S54.
32. Sniderman AD, Blank D, Zakarian R, Bergeron J, Frohlich J. Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. Clin Biochem. 2003;36:499-504.
33. American Heart Association. Cholesterol levels. Available from: http:// www.americanheart.org/presenter.jhtml?identifiera4500. Accessed November 14, 2009.
34. American Heart Association. What do my cholesterol levels mean? September 2007. Available from: http://www.americanheart.org/ downloadable/heart/119618151049911%20CholLevels%20907.pdf. Accessed November 14, 2009.
35. Saleem T, Mohammad KH, Abdel-Fattah MM, Abbasi AH. Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease. Diab Vasc Dis Res. 2008;5:184-189.
36. Wilkinson CP, Ferris FL, Klein RE, et al: Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677-1682.
37. Watkins PJ, Amiel S, Howell SL, Turner E. Diabetes and its Management. 6th ed. Oxford, UK: Blackwell Science; 2003.
38. El Haddad OA, Saad MK. Prevalence and risk factors for diabetic retinopathy among Omani diabetics. Br J Ophthalmol. 1998;82:901-906.
39. Kilpatrick ES, Rigby AS, Atkin SL. The Diabetes Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol. 2009;5:537-545.
40. Nguyen TT, Wong TY. Retinal vascular changes and diabetic retinopathy. Curr Diab Rep. 2009;9:277-283.
41. Weber C, Schnell O. The assessment of glycemic variability and its impact on diabetes-related complications: an overview. Diabetes Technol Ther. 2009;11:623-633.
42. Al-Khaldi YM, Khan MY, Khairallah SH. Audit of referral of diabetic patients. Saudi Med J. 2002;23:177-181.
43. He S, Guo Y, Li Z. Epidemiologic study of diabetic retinopathy in Capital Steel Company. Zhonghua Yan Ke Za Zhi. 1997;33:381-383. Chinese.
44. Seyoum B, Mengistu Z, Berhanu P, et al. Retinopathy in patients of Tikur Anbessa Hospital diabetic clinic. Ethiop Med J. 2001;39:123-131.
45. Donnio-Cordoba A, Richer R, Spinelli F, et al. Diabetic retinopathy in Martinique: results of a cross-sectional survey based on 771 patients. J Fr Ophtalmol. 2001;24:603-609. French.
46. Funatsu H, Suto C, Hori S, et al. Prevalence of diabetic ocular complications and systemic factors. Nippon Ganka Gakkai Zasshi. 1993; 97:947-954. Japanese.
47. Bresnick GH. Diabetic retinopathy. In: Principles and Practice of Ophthalmology. 1st ed. Philadelphia, PA: WB Saunders; 1987.
48. Khandekar R, Al Lawatii J J, Mohammed AJ, Al Raisi A. Diabetic retinopathy in Oman: a hospital based study. Br J Ophthalmol. 2003; 87:1061-1064.
49. Jerneld B, Algvere P. Relationship of duration and onset of diabetes to prevalence of diabetic retinopathy. Am J Ophthalmol. 1986;102:431-437.
50. Segal P, Treister G, Yalon M, et al. The prevalence of diabetic retinopathy: effect of sex, age, duration of disease and mode of therapy. Diabetes Care. 1983;6:149-151.
51. Araki A, Ito H, Hattori A, et al. Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus. Diabetes Care. 1993;16:1184-1186.
52. Al-Maskari F, El-Sadig M. Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol. 2007;16:7-11.
53. Tapp RJ, Zimmet PZ, Harper CA, et al. Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Res Clin Pract. 2006;73:298-303.